NASDAQ:TEM Tempus AI Q3 2026 Earnings Date & Estimates $64.34 -0.38 (-0.59%) Closing price 04:00 PM EasternExtended Trading$64.31 -0.03 (-0.05%) As of 06:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Tempus AI is scheduled to report Q3 2026 earnings on Monday, November 2, 2026, after market closes. The conference call is scheduled for 8:45 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 2, 2026TimeAfter Market ClosesConference Call8:45 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Tempus AI in Q3 2026Tempus AI is expected to post earnings of -$0.0751 per share on revenue of $409.39 million. In the same quarter a year earlier Tempus AI reported -$0.11 per share on revenue of $334.21 million. Tempus AI last reported on July 30, 2026, posting -$0.04 per share and beating the -$0.1428 consensus estimate. Tempus AI has beaten the consensus EPS estimate in 5 of its last 7 quarters.Consensus EstimatesConsensus EPS-$0.0751Expected Revenue$409.39 millionPrior-Year EPS-$0.11Prior-Year Revenue$334.21 millionExpected Revenue Growth+22.5%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.04 (Beat by +$0.1028)Last Quarter Revenue$382.49 millionEPS Beat Rate5 of last 7 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ3 2025 Earnings Report Tempus AI Q3 2026 Earnings FAQ When does Tempus AI report Q3 2026 earnings? Tempus AI (NASDAQ:TEM) has confirmed it will report Q3 2026 earnings on Monday, November 2, 2026, after market closes. What time is Tempus AI's Q3 2026 earnings call? Tempus AI's Q3 2026 earnings conference call is scheduled for Monday, November 2, 2026 at 8:45 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Tempus AI? Analysts expect Tempus AI to post earnings of -$0.0751 per share for Q3 2026. How much revenue is Tempus AI expected to report? The consensus revenue estimate for Tempus AI is $409.39 million for Q3 2026. Tempus AI Earnings HeadlinesTempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLCOctober 19 at 9:00 AM | businesswire.comTempus AI Stock Is The Expanded Drug Collaboration Material To The Bull CaseOctober 17 at 6:10 PM | finance.yahoo.comMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.October 19 at 1:00 AM | The Oxford Club (Ad)Tempus AI (NASDAQ:TEM) Stock Gets Price Target Bump from JPMorgan Chase & Co.October 16 at 1:18 AM | americanbankingnews.comTempus to Report Third Quarter 2026 Financial Results on November 2October 15, 2026 | businesswire.comTempus AI's Ambry Genetics Launches GenomeNext To Improve Rare Disease DiagnosisOctober 13, 2026 | rttnews.comSee More Tempus AI Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Tempus AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tempus AI and other key companies, straight to your email. Email Address About Tempus AITempus AI (NASDAQ:TEM) is a healthcare technology company that uses artificial intelligence and data analytics to support precision medicine. The company combines clinical, molecular and imaging data to help physicians make more informed treatment decisions and to help researchers and biopharmaceutical companies develop therapies. Its offerings include genomic testing and analysis, such as tissue- and blood-based tests, as well as software tools designed to assist with clinical decision-making, patient matching for clinical trials and the management of healthcare data. Tempus also provides data and analytics services to biopharmaceutical companies and other life sciences organizations. Tempus was founded in 2015 by Eric Lefkofsky, who serves as its chief executive officer. Headquartered in Chicago, the company primarily serves healthcare providers, researchers and life sciences companies in the United States. Tempus became a publicly traded company on the Nasdaq under the symbol TEM in 2024.View Tempus AI ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Tesla's Roadster Reveal Hints at 2 Much Bigger MovesThe AI Sell-Off Continues—These 3 Stocks Keep Raising Guidance AnywayRate-Resilient vs. Rate-Exposed: Why Homebuilder Stocks Are DivergingMarketBeat Week in Review – 10/12 - 10/16Alcoa Beat Earnings, But Can It Escape the Aluminum Bears?Could a Trucking Squeeze Become J.B. Hunt’s Biggest Edge?Meta Claims Frontier-Class AI Status With New Muse Wonder Models Upcoming Earnings America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026)Northrop Grumman (10/20/2026)RTX (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
